According to a letter issued on February 18th in the U.S. District Court for the District of Minnesota, the federal judge overseeing lawsuits involving the Stryker Rejuvenate and ABG II modular-neck hip stems is requesting input on how the coordination of claims among state and federal litigations could “effectuate a meaningful and prompt resolution of those cases.” At the time the document was sent to judges in Michigan, Oregon and Illinois, Judge Frank noted that 100 cases over the metal hip replacements had been filed in these courts, and approximately 575 Stryker hip recall claims were pending in the federal litigation.
The federal judge also predicted that 1,000 additional lawsuits alleging pain, swelling and symptoms associated with metallosis would be filed over the Stryker Rejuvenate and ABG II devices over the coming months. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Stryker Hip Recall
Court documents indicate that the number of federally-filed Stryker hip recall lawsuits is continuing to increase in the District of Minnesota. As of February 19th, an update from the U.S. Judicial Panel on Multidistrict Litigation (JPML) showed 576 claims pending in the Southern District of Minnesota on behalf of individuals who allege injuries associated with a voluntary recall issued almost two years ago by Stryker Orthopaedics. This recall was announced by the U.S. Food and Drug Administration (FDA) on July 6, 2012 after company data revealed the potential for components to fret and corrode at the modular-neck junction, which may result in premature failure of the device. According to recent records, the most recent Case Management Conference in the federal multidistrict Stryker lawsuit litigation took place on February 20, 2014.